ASTH (NASDAQ: ASTH) reported Q2 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $486.3 million versus the consensus estimate of $440.74 million.

GUIDANCE:

ASTH sees FY2024 EPS of $1.12-$1.36, versus the consensus of $2.13. ASTH sees FY2024 revenue of $1.75-1.85 billion, versus the consensus of $1.762 billion.

For earnings history and earnings-related data on ASTH (ASTH) click here.